Issue | Pharma's Almanac

Current Issue: Q3 2018

The Outsourcing Issue

Also In This Issue

Continuing on the Acquisition Trail: Building Out a World-Class, Customer-Oriented CDMO

Pharmaceutical companies need contract development and manufacturing partners that can act as extensions of their businesses, reliably providing on-time and in-full delivery of end-to-end, customized support from discovery through commercialization. Avara Pharmaceutical Services was founded in 2015 to fill this gap in the market. Through ongoing acquisitions of world-class facilities from leading pharmaceutical companies, Avara continues […]

Capsule Manufacturing

Optimizing Profitability in Drug Product Manufacturing with Hard-Shell Capsules

When evaluating different dosage forms, it is clear that hard-shell capsules provide significant advantages over other types of solid dose: they are more simple to formulate and easier to produce. With support from the right partner in terms of quality, technical services and training, drug manufacturers can increase productivity and optimize the profitability of oral […]

CDMO

Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector

Industry Leader Insight Biopharmaceutical drug developers are increasingly relying on contract development and manufacturing organizations (CDMOs) to provide the specialized knowledge, expertise and technologies required to accelerate the development and commercialization of these important medicines. Dedicated CDMOs that are focused solely on serving their customers — and who can also provide integrated support throughout the […]

CDMO

Aspects to Consider on the Way to a Tailored Manufacturing Strategy

Drug development and manufacturing is demanding. To achieve the best results from clinical trials to commercial manufacturing, an organization must consider all possible alternatives and strategies around production. For a pharmaceutical or biotech company, it is critical to consider not only drug development but also to develop a thoughtful commercial manufacturing strategy designed to achieve […]

Fermentation

People, Expertise and Dedication are Key to Successful Strategic Partnerships

Capua BioServices (“Capua”) has been executing fermentation processes for over 50 years, and, thanks to our highly experienced staff, the company has been able to develop into a contract development and manufacturing organization (CDMO) with a strong reputation that enables the rapid development and scale-up of optimized manufacturing solutions. Adding Value to Strategic Partnerships While […]

Multi-Product Manufacturing

Leveraging Offsite Fabrication in the Pharma Industry

The pharmaceutical industry is evolving rapidly. New facilities for the production of next-generation medicines must be designed and built quickly and cost-effectively while ensuring the highest possible levels of quality and safety during construction, commissioning and start-up. Offsite fabrication of facility components and equipment can help drug manufacturers achieve these goals. Prefabrication has been used in […]

Cell and Gene Therapy

Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing

Expertise in a wide variety of analytical techniques is required for the detection and characterization of the protein and nucleic acid components of viral vector products and any impurities. Analyses of process- and product-related impurities are performed to ensure the manufacture of high-quality therapeutic viral vectors. In many cases, customized assays must be developed. CDMOs […]

Gene Therapy

Understanding the Unique Design and Engineering Needs for Gene Therapy Production

As growing numbers of gene therapies progress to later clinical stages and demonstrate a high likelihood of regulatory approval, commercial manufacturing capacity must expand. Processes for the production of gene therapies vary greatly and require high levels of containment. These differentiating factors lead to unique design and engineering needs for the equipment and the manufacturing […]

Design Logic

A Biopharmaceutical Leader Emerges

Design Logic: Polpharma Biologics Website Launch The biopharmaceuticals division of a leading European generics manufacturer showcases its capabilities as both a CDMO and a developer of its own novel biologics and biosimilars. Polpharma Group is the leading manufacturer of drugs in Poland and one of the largest pharmaceutical companies in Central and Eastern Europe. […]

Past Issues

View all Past Issues

The Advanced Therapeutics Issue

View Issue »

Issue #2 | Volume #5 | Q2 2019

The Executive Issue

View Issue »

Issue #1 | Volume #6 | Q1 2020

The Role of Innovative Technologies

View Issue »

Issue #4 | Volume #2 | Q4 2016

Market Landscape

View Issue »

Issue #1 | Volume #3 | Q1 2017